Dr. Carl Ehmann is a former Chairman of the FRD Board of Directors. During his career, Dr. Ehmann was the Research and Development leader of several large multi-national companies includingBristol-Myers(Dermatology),Johnson & JohnsonConsumer Products Company, Reynolds Technology Inc. and Reckitt & Coleman. Dr. Ehmann began his industrial research career atHoffmann-LaRoche Pharmaceutical Company, eventually becoming head of its dermatological group. This group was responsible for the development of the breakthrough therapeutics for severe dermatological diseases including the first systemic retinoid, Accutane.